These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30326074)

  • 1. Dark Spot in Fibrinous Central Serous Chorioretinopathy.
    Singh SR; Dogra M; Dogra MR
    JAMA Ophthalmol; 2018 Oct; 136(10):e182924. PubMed ID: 30326074
    [No Abstract]   [Full Text] [Related]  

  • 2. Dark and white lesions observed in central serous chorioretinopathy on optical coherence tomography angiography.
    De Bats F; Cornut PL; Wolff B; Kodjikian L; Mauget-Faÿsse M
    Eur J Ophthalmol; 2018 Jul; 28(4):446-453. PubMed ID: 29554817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dark spot in fibrinous central serous chorioretinopathy masquerading choroiditis.
    Parchand S; Gupta V; Gupta A; Dogra MR; Singh R; Sharma A
    Ocul Immunol Inflamm; 2013 Jun; 21(3):201-6. PubMed ID: 23472760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of three-dimensional optical coherence tomography and fundus photochromy in correlating the fluorescein leaking sites of acute central serous chorioretinopathy.
    Wang GH; Zhang J; Zhang D; Lv FL; Wang LX
    Med Princ Pract; 2011; 20(3):283-6. PubMed ID: 21455001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and therapeutic challenges.
    Gupta OP; Garg SJ; Negrey JN; Jahnle R; Pasion R; Ip MS; Hwang FS; Kaines A; Jain AK; Schwartz SD
    Retina; 2010 Jun; 30(6):975-80. PubMed ID: 20531147
    [No Abstract]   [Full Text] [Related]  

  • 8. Central Serous Chorioretinopathy.
    Daruich A; Matet A; Behar-Cohen F
    Dev Ophthalmol; 2017; 58():27-38. PubMed ID: 28351043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photopigments in central serous chorioretinopathy.
    Ojima A; Iida T; Sekiryu T; Maruko I; Sugano Y
    Am J Ophthalmol; 2011 Jun; 151(6):940-952.e1. PubMed ID: 21457927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.
    Koytak A; Erol K; Coskun E; Asik N; Öztürk H; Özertürk Y
    Retina; 2010; 30(10):1698-703. PubMed ID: 20539254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central Serous Chorioretinopathy in a Patient with Ectopic Adrenocorticotropic Hormone-secreting Tumor.
    Chen KJ; Wang NK; Shen JH
    Ophthalmology; 2017 Jun; 124(6):821. PubMed ID: 28528827
    [No Abstract]   [Full Text] [Related]  

  • 12. Central serous chorioretinopathy in young adults.
    Pryds A; Larsen M; Barbazetto I; Yannuzzi L
    Acta Ophthalmol; 2012 Aug; 90(5):e404-5. PubMed ID: 23043628
    [No Abstract]   [Full Text] [Related]  

  • 13. Central serous chorioretinopathy in myopic patients.
    Yzer S; Fung AT; Barbazetto I; Yannuzzi LA; Freund KB
    Arch Ophthalmol; 2012 Oct; 130(10):1339-40. PubMed ID: 23044956
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanding the OCT Spectrum of Acute Central Serous Chorioretinopathy: The Stalagmite-Stalactite Pattern.
    Ramtohul P; Comet A; Denis D
    Ophthalmol Retina; 2019 Aug; 3(8):636. PubMed ID: 31383396
    [No Abstract]   [Full Text] [Related]  

  • 15. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.
    Lee H; Lee J; Chung H; Kim HC
    Retina; 2016 Jul; 36(7):1372-80. PubMed ID: 26702841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Masqueraders of central serous chorioretinopathy.
    Sahoo NK; Singh SR; Rajendran A; Shukla D; Chhablani J
    Surv Ophthalmol; 2019; 64(1):30-44. PubMed ID: 30243734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bilateral abnormalities in central serous chorioretinopathy seen in optical coherence tomography, ultra-widefield fluorescein angiography and microperimetry--case report].
    Tylus M; Święch-Zubilewicz A; Dolar-Szczasny J; Mackiewicz J
    Klin Oczna; 2015; 117(3):173-6. PubMed ID: 26999941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
    Dysli C; Berger L; Wolf S; Zinkernagel MS
    Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of a fibrinous exudation in fibrinous central serous chorioretinopathy. The "Y" sign.
    Sánchez-Sevila JL; Rodrigo-Auria F
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Sep; 94(9):e66. PubMed ID: 31151688
    [No Abstract]   [Full Text] [Related]  

  • 20. Spectral domain optical coherence tomography predates fluorescein angiography in diagnosing central serous chorioretinopathy.
    Gupta V; Gupta A; Gupta P
    Indian J Ophthalmol; 2010; 58(2):173-5. PubMed ID: 20195055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.